Federal Register
Notice: FDA is making available a draft guidance entitled Pharmacogenetic Tests and Genetic Tests for Heritable Markers intended to provide guidance on preparing and reviewing PMAs and 510(k) submissions for pharmacogenetic and other genetic tests, whether testing is for single markers or for multiple markers simultaneously (multiplex tests). To download this guidance, click here. To view this notice, click here.